You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,478,560


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,478,560
Title:Prefilled syringe injector
Abstract: A jet injector that includes a prefilled syringe. The syringe includes a fluid chamber that contains a medicament. The syringe also has an injection-assisting needle, and a plunger is movable within the fluid chamber. A housing is configured for allowing insertion of the needle to a penetration depth. An energy source is configured for biasing the plunger to produce an injecting pressure in the medicament in the fluid chamber of between about 80 and 1000 p.s.i. to jet inject the medicament from the fluid chamber through the needle to an injection site.
Inventor(s): Lesch; Paul R. (Lino Lakes, MN)
Assignee: Antares Pharma, Inc. (Ewing, NJ)
Application Number:15/493,494
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 10,478,560

Introduction

United States Patent 10,478,560, titled "Prefilled Syringe Injector," is a significant innovation in the field of medical devices, particularly in the realm of injection technology. This patent, granted to its inventors, outlines a novel design for a needle-assisted jet injector that utilizes a low jet injection pressure. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Invention

The patent for the "Prefilled Syringe Injector" addresses a critical need in medical technology: the efficient and safe administration of medications via injection. Traditional syringe injectors often require manual handling of needles, which can be risky and cumbersome. The invention described in this patent aims to mitigate these issues by introducing a prefilled, needle-assisted jet injector that operates at a low jet injection pressure[5].

Scope of the Patent

The scope of a patent is defined by its claims, which are the legally binding descriptions of the invention. For US Patent 10,478,560, the scope includes:

Independent Claims

Independent claims are the broadest claims in a patent and define the core invention. In this case, the independent claims cover the overall design and functionality of the prefilled syringe injector, including the use of a low jet injection pressure and the integration of a needle-assisted mechanism[5].

Dependent Claims

Dependent claims are narrower and build upon the independent claims. They often specify particular aspects or variations of the invention. For example, dependent claims might detail specific materials used in the construction of the injector, the design of the needle, or the mechanism for triggering the injection[5].

Claim Analysis

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be indicative of the patent's scope and quality. Generally, narrower claims with fewer independent claims are associated with a higher probability of grant and a shorter examination process[3].

Claim Language

The language used in the claims is crucial for defining the scope of the patent. Clear and concise language helps in avoiding ambiguity and ensures that the patent is not overly broad or vague. In the case of US Patent 10,478,560, the claims are detailed enough to specify the unique features of the prefilled syringe injector while avoiding overly broad statements that could lead to validity issues[3].

Patent Landscape

Prior Art

The patent landscape for US Patent 10,478,560 includes an analysis of prior art, which involves reviewing existing patents and publications related to syringe injectors and jet injection technology. The prior art keywords listed in the patent, such as "injector," "syringe," "medicament," "needle," and "injection," indicate the areas where the invention improves upon existing technologies[5].

Classification

The Cooperative Patent Classification (CPC) scheme is used to categorize patents. For medical devices like the prefilled syringe injector, classifications might include A61M (Devices for Introducing Media into, or onto, the Body) or A61B (Diagnosis; Surgery; Identification). Understanding these classifications helps in identifying similar patents and tracking innovation trends in the field[4].

International Context

The global patent landscape for similar inventions can be explored through databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE. These resources provide insights into how similar technologies are being developed and patented in other countries[1].

Examination Process

Patent Examination Data System (PEDS)

The examination process for US Patent 10,478,560 can be analyzed using the Patent Examination Data System (PEDS), which provides bibliographic data for all publicly available patent applications. This system allows users to track the progress of the patent application, including any office actions, responses, and the final outcome[1].

Response Times and Rejections

Research indicates that the response times to the first Non-Final Rejection can vary significantly depending on the patent classification. For example, applications in the H (Electricity) and G (Physics) classifications tend to have faster responses compared to those in the C (Chemistry) classification. Understanding these trends can help in anticipating the examination process for similar patents[4].

Economic and Innovation Impact

Historical Innovation Trends

Economists often study patent filings to understand historical innovation trends. The Cooperative Patent Classification scheme can be used to aggregate sets of patents over time, showing trends in innovation. For instance, patent filings in specific areas like medical devices can indicate periods of significant technological advancement[4].

Licensing and Litigation

The scope and claims of a patent can significantly impact licensing and litigation costs. Patents with narrower, clearer claims tend to reduce the risk of litigation and make licensing more straightforward. This is particularly important in the medical device sector, where intellectual property disputes can be costly and time-consuming[3].

Key Takeaways

  • Clear Claims: The patent's claims are detailed and specific, avoiding ambiguity and ensuring the patent is not overly broad.
  • Innovation: The prefilled syringe injector represents a significant innovation in medical technology, addressing safety and efficiency concerns.
  • Global Context: Understanding the global patent landscape through international databases is crucial for identifying similar technologies and tracking innovation trends.
  • Examination Process: Analyzing the examination process using PEDS can provide insights into the patent's journey and potential challenges.
  • Economic Impact: The patent's scope and claims can influence licensing and litigation costs, impacting the overall economic viability of the invention.

FAQs

What is the main innovation of US Patent 10,478,560?

The main innovation is a prefilled syringe injector that uses a low jet injection pressure and a needle-assisted mechanism, enhancing safety and efficiency in medication administration.

How can the scope of a patent be measured?

The scope of a patent can be measured using metrics such as independent claim length and independent claim count, which have been shown to have explanatory power for several correlates of patent scope[3].

What databases can be used to search for similar patents internationally?

Databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE can be used to search for similar patents internationally[1].

How does the Cooperative Patent Classification scheme help in tracking innovation trends?

The Cooperative Patent Classification scheme allows for the aggregation of sets of patents over time, showing trends in innovation in specific areas such as medical devices[4].

What is the significance of the Patent Examination Data System (PEDS)?

PEDS provides public users with the ability to search, view, and download bibliographic data for all publicly available patent applications, helping to track the examination process and outcomes[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Google Cloud Blog - Connecting public, paid, and private patent data: https://cloud.google.com/blog/topics/public-datasets/google-patents-public-datasets-connecting-public-paid-and-private-patent-data?hl=en
  5. Google Patents - Prefilled syringe injector: https://patents.google.com/patent/US10478560B2/en

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,478,560

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Purdue Pharma Lp ZURNAI (AUTOINJECTOR) nalmefene hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 218590-001 Aug 7, 2024 RX Yes Yes 10,478,560 ⤷  Subscribe Y ⤷  Subscribe
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-001 Sep 28, 2018 RX Yes Yes 10,478,560 ⤷  Subscribe Y ⤷  Subscribe
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes 10,478,560 ⤷  Subscribe Y ⤷  Subscribe
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes 10,478,560 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,478,560

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil PI0614025 ⤷  Subscribe
Canada 2595730 ⤷  Subscribe
China 101132820 ⤷  Subscribe
Denmark 1850892 ⤷  Subscribe
European Patent Office 1850892 ⤷  Subscribe
European Patent Office 3495009 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.